U.S. Semiconductors Stock News

NasdaqGS:INMD
NasdaqGS:INMDMedical Equipment

InMode Weighs Steel Partners Offer And Future Earnings Pressure

InMode (NasdaqGS:INMD) confirmed it received a non binding proposal from Steel Partners Holdings L.P. to acquire a majority stake. The board has formed an independent committee to evaluate this proposal and consider a range of potential alternatives. The review process is underway and could result in a change of control or other significant outcomes for existing shareholders. InMode focuses on medical devices for aesthetic and wellness procedures, an area that sits at the intersection of...
NYSE:J
NYSE:JProfessional Services

Jacobs Solutions (J) Margin Volatility Tests Bullish Earnings Narratives After Q1 2026 Results

Jacobs Solutions (J) opened fiscal Q1 2026 with revenue of about US$3.3b and basic EPS of US$1.12, setting the tone for how the year is starting after a busy 2025. The company has seen quarterly revenue move from roughly US$2.9b in Q1 2025 to US$3.3b in the latest quarter, while basic EPS shifted from a small loss of about US$0.10 to a profit of US$1.12, a swing that puts the focus firmly on how sustainable those margins prove to be. See our full analysis for Jacobs Solutions. With the...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Nurix Therapeutics (NRIX) Is Down 7.4% After Pivotal Bexobrutideg Update and Wider 2025 Loss

In late January 2026, Nurix Therapeutics reported full-year 2025 revenue of US$83.98 million, up from US$54.55 million, alongside a wider net loss of US$264.46 million and an Employee Stock Ownership Plan-related shelf registration for up to 5,090,373 common shares worth about US$98.80 million. The results came as Nurix advanced its lead BTK degrader bexobrutideg into pivotal DAYBREAK development with Orphan Drug and Fast Track status, backed by partnerships with Gilead, Sanofi, and Pfizer...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

NXP Refocuses On Automotive And AI As MEMS And RF Power Exit

NXP Semiconductors has completed the sale of its MEMS sensor business. The company is exiting new RF Power developments and winding down that activity. Management is concentrating resources on software-defined vehicles, physical AI, and industrial/IoT opportunities. These moves come as NXP adjusts its portfolio in the context of margin and inventory pressures. NXP Semiconductors (NasdaqGS:NXPI) is reshaping its business around areas it views as core to its future identity, while stepping...
NasdaqGS:COLM
NasdaqGS:COLMLuxury

Columbia Sportswear (COLM) Margin Compression Reinforces Bearish Profitability Narratives

Columbia Sportswear (COLM) has wrapped up FY 2025 with fourth quarter revenue of US$1.1b and basic EPS of US$1.74, alongside net income excluding extra items of US$93.2 million. This set of results kept margins firmly in focus for the year. Over recent periods, the company has seen quarterly revenue move from US$931.8 million and EPS of US$1.56 in Q3 2024 to US$1.1b and EPS of US$1.74 in Q4 2025, while trailing twelve month EPS of US$3.24 sits against total revenue of about US$3.4b. With net...
NasdaqGS:CBC
NasdaqGS:CBCBanks

Is Central Bancompany (CBC) Pricing Reflect Its Strong Multi‑Year Share Price Performance

If you are wondering whether Central Bancompany's current share price lines up with its underlying value, you are not alone. The stock last closed at US$24.52, with returns of 1.9% over 7 days, 2.9% over 30 days, 2.8% year to date and 89.2% over 1 year, plus 99.0% over 3 years and 142.0% over 5 years. Recent attention on Central Bancompany has centered on its share price performance and how it fits into investors' views on regional bank stocks. This has put more focus on whether the current...
NYSE:SHW
NYSE:SHWChemicals

Is Sherwin-Williams (SHW) Pricing In Too Much Optimism After Its Recent Share Price Strength

With Sherwin-Williams trading at around US$368.91, this article explores whether the stock is priced for perfection or still offers some value, and walks through what the current share price might be telling you. The stock has returned 5.5% over the last 7 days, 11.1% over the last 30 days, 12.5% year to date, 2.1% over 1 year, 60.9% over 3 years, and 62.4% over 5 years. These figures provide important context for any view on value today. Recent coverage has focused on Sherwin-Williams as a...
NYSE:DOC
NYSE:DOCHealth Care REITs

Healthpeak Properties (DOC) Posts Steady FFO Challenging Bearish Cash Flow Narratives

Latest FY 2025 results set the stage Healthpeak Properties (DOC) has wrapped up FY 2025 with Q4 revenue of US$719.4 million, basic EPS of US$0.16, and Funds From Operations of US$328.6 million, giving investors a fresh read on both reported earnings and REIT cash generation. Over the past six quarters, revenue has ranged from US$694.3 million to US$719.4 million a quarter, while EPS has moved between a loss of US$0.17 and a profit of US$0.16. This highlights how accounting earnings can swing...
NYSE:URI
NYSE:URITrade Distributors

Is It Too Late To Consider United Rentals (URI) After Recent Share Price Pullback?

For readers considering whether United Rentals at around US$848 a share is still a solid deal or if the easy money has already been made, this article explains what the current price implies about value. The stock has had a mixed run, with a 6.1% decline over the last 7 days and a 4.4% decline over the last 30 days, while still showing a 15.9% return over 1 year, 90.6% over 3 years, and 216.3% over 5 years. Recent attention on United Rentals has focused on its role as a major equipment...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Capital Southwest JV Targets First Out Loans And Potential Value Upside

Capital Southwest (NasdaqGS:CSWC) has formed a joint venture with a private credit asset manager to target first out senior secured debt in the lower middle market. The partnership introduces an off balance sheet private fund structure that aims to widen Capital Southwest's deal access and funding options. The move is intended to expand the range of capital solutions available to clients and may influence future shareholder returns. At a current share price of $23.22, Capital Southwest...
NYSE:ATO
NYSE:ATOGas Utilities

Atmos Energy (ATO) Q1 EPS Strength Reinforces Bullish Earnings Growth Narratives

Atmos Energy (ATO) opened fiscal Q1 2026 with revenue of US$1.3b and EPS of US$2.48, alongside trailing twelve month revenue of US$4.9b and EPS of US$7.78 that frame the latest print within a steadily building earnings profile. Over recent quarters, revenue has moved from US$1.2b in Q1 2025 to US$1.3b in Q1 2026, while quarterly EPS has shifted from US$2.25 to US$2.48, supported by trailing twelve month net income of about US$1.2b. This keeps the focus firmly on how durable current margin...
NYSE:PAR
NYSE:PARSoftware

Assessing PAR Technology (PAR) Valuation After Recent Share Price Pullback

PAR Technology stock performance snapshot PAR Technology (PAR) has drawn investor attention after a sharp pullback, with the share price at $23.57 and negative returns over the past week, month, past 3 months, year, and 5 years. See our latest analysis for PAR Technology. At the current share price of $23.57, PAR Technology’s short term momentum has weakened, with a 7 day share price return of 17.44% and a 30 day share price return of 34.89%, while the 1 year total shareholder return of...
NYSE:HMN
NYSE:HMNInsurance

Improved Combined Ratios And 9.5% Net Margin Challenge Horace Mann Educators Valuation Concerns

Horace Mann Educators (HMN) just wrapped up FY 2025 with Q4 revenue of US$434.8 million and basic EPS of US$0.89, rounding out a year in which trailing twelve month revenue reached about US$1.7 billion and EPS came in at roughly US$3.97. The company has seen quarterly revenue move from US$409 million in Q4 2024 to US$434.8 million in Q4 2025, with basic EPS over that span ranging between US$0.71 and US$1.42, highlighting how efficiently those premiums and fees are translating into profit. For...
NasdaqGM:SGMT
NasdaqGM:SGMTBiotechs

Assessing Sagimet Biosciences (SGMT) Valuation After Positive Denifanstat Phase 3 Acne Trial Results

Sagimet Biosciences (SGMT) is back on investors’ radar after partner Ascletis Pharma reported that Denifanstat, also known as ASC40, met all primary and secondary endpoints in a Phase 3 acne trial. See our latest analysis for Sagimet Biosciences. Despite the positive Phase 3 acne data, Sagimet’s 1 day share price return was a 7.32% decline to US$6.08. Its 30 day share price return of 9.75% contrasts with a 20.94% decline over 90 days and a 1 year total shareholder return of 18.52%, suggesting...
NasdaqGS:JJSF
NasdaqGS:JJSFFood

J&J Snack Foods (JJSF) Margin Squeeze Challenges Bullish Earnings Growth Narratives

J&J Snack Foods (JJSF) opened fiscal 2026 with Q1 revenue of US$343.8 million and basic EPS of US$0.05, while trailing twelve month revenue stood at about US$1.6 billion with EPS of US$3.16. Over recent quarters the company has seen revenue move from US$426.8 million in Q4 2024 to US$454.3 million in Q3 2025 and US$410.2 million in Q4 2025, alongside quarterly EPS figures that ranged from US$1.52 to US$2.27 over that stretch before the latest step down. With trailing net margins compressing...
NasdaqGM:PDYN
NasdaqGM:PDYNMachinery

Are Palladyne AI’s (PDYN) New Defense Wins Quietly Redefining Its Core Competitive Moat?

Palladyne AI Corp. recently announced two defense wins: a mission-critical missile propulsion subsystem contract with a major U.S. defense prime and an Air Force Research Laboratory HANGTIME award leveraging its SwarmOS™ platform for coordinated autonomous systems across space, air, maritime, and land. Together, these contracts deepen Palladyne AI’s role in the U.S. defense industrial base, extend its technology stack into satellites, and add roughly US$1,000,000 of expected 2026 revenue...
NasdaqGS:CNXN
NasdaqGS:CNXNElectronic

Assessing PC Connection (CNXN) Valuation After Recent Share Price Moves

Why PC Connection is on investors’ radar today PC Connection (CNXN) has attracted attention after recent share price moves, with the stock closing at $60.15. That is putting fresh focus on how its current valuation compares with its fundamentals. See our latest analysis for PC Connection. Recent moves, including a 2.31% 1 day share price return and a 5.75% year to date share price return, sit alongside a 1 year total shareholder return of 15.34% decline. As a result, short term momentum...
NasdaqGS:GLBE
NasdaqGS:GLBEMultiline Retail

Global E Online Partnership Renewal With Shopify And Shift To Profitability

Global-E Online (NasdaqGS:GLBE) renewed its multi-year commercial partnership with Shopify, reinforcing its role in supporting Shopify merchants with cross border e-commerce solutions. The company recently reported GAAP profitability, reaching a key profitability threshold alongside its existing relationship with one of the largest e-commerce platforms. Global-E Online focuses on helping brands sell internationally by handling localization, payments, and logistics for cross border...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity (RVTY) Deepens AI And Buybacks Strategy: Is Diagnostics Now Its Core Value Engine?

In early February 2026, Revvity, Inc. reported fourth-quarter 2025 results showing higher sales of US$772.06 million and improved earnings, as well as full-year 2025 revenue of US$2.86 billion alongside lower net income and diluted EPS than the prior year. Beyond the headline beat, management highlighted 7% organic growth in the diagnostics segment, share repurchases of over US$800 million, and new AI-enabled drug discovery tools such as Signals Synthetica as evidence of progress in the...
NYSE:CDP
NYSE:CDPOffice REITs

A Look At COPT Defense Properties (CDP) Valuation As Earnings Optimism Lifts Recent Share Price Moves

COPT Defense Properties earnings anticipation and recent stock move COPT Defense Properties (CDP) is back in focus as traders position ahead of its February 5, 2026 quarterly earnings release, with expectations centered on an earnings per share figure of $0.47. The stock has drawn interest as investors weigh those earnings expectations, recent share price gains over the past month, and relatively modest annual revenue growth compared with other real estate names. See our latest analysis for...
NYSE:IEX
NYSE:IEXMachinery

Idex (IEX) Margin Compression Tests Bullish Premium P E Narrative

IDEX (IEX) closed out FY 2025 with Q4 revenue of US$899.1 million and basic EPS of US$1.72, alongside net income of US$128.3 million, setting the tone for how investors digest the latest print. Over the last few quarters, the company has seen revenue move from US$862.9 million in Q4 2024 to US$899.1 million in Q4 2025, while basic EPS shifted from US$1.63 to US$1.72. This gives a clearer picture of how the top line and per share earnings have tracked together. With a trailing net profit...
NYSE:ALL
NYSE:ALLInsurance

Allstate’s Bigger Payouts And Buyback Raise Questions On Future Returns

Allstate (NYSE:ALL) announced a significant dividend increase following its Q4 results. The company also authorized a new $4b share repurchase program. These capital return measures were introduced after reporting strong Q4 performance. Allstate is a major US property and casualty insurer, with a core focus on auto and home coverage for retail customers. The latest capital return announcement arrives as insurers continue to manage claims costs, pricing, and catastrophe exposure. All of...
NYSE:AYI
NYSE:AYIElectrical

Does Acuity’s 17% Dividend Hike Reshape The Capital Return Story For AYI?

Acuity Inc.’s Board of Directors has approved a 17% increase in the quarterly dividend to US$0.20 per share, payable on February 13, 2026, to shareholders of record as of February 2, 2026. This dividend hike highlights the company’s willingness to return more cash to shareholders, which can be an important signal about management’s view of its financial position. We will now examine how Acuity’s 17% dividend increase shapes its broader investment narrative and what it may indicate for...
NasdaqCM:OPTX
NasdaqCM:OPTXElectronic

Does Syntec Optics (OPTX) Sentiment Shift Reveal a Deeper Turn in Its Governance Narrative?

Syntec Optics Holdings, Inc. recently saw stockholders approve an amendment to its Second Amended and Restated Certificate of Incorporation at the January 20, 2026 annual meeting, while January short interest fell and a hedge fund added a new position alongside mixed analyst views. Taken together, the governance change, reduced short positioning, and fresh institutional interest highlight shifting sentiment signals that many investors monitor closely. We’ll now explore how the sharp decrease...